NCT06242730View on ClinicalTrials.gov

Doxycycline PEP and 4CMenB as a Comprehensive Prevention Strategy in MSM and TGW at High Risk for Bacterial STIs Within the Swiss HIV Cohort Study

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2025

Conditions

Doxycycline STI PEP

Trial Locations (1)

8091

RECRUITING

University Hospital Zurich, Zurich

All Listed Sponsors

collaborator

Swiss HIV Cohort Study

NETWORK

lead

University of Zurich

OTHER